CINECA IRIS Institutional Research Information System

MARTELLI, ALMA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 16.744
AS - Asia 7.453
EU - Europa 5.813
SA - Sud America 994
Continente sconosciuto - Info sul continente non disponibili 661
AF - Africa 305
OC - Oceania 15
Totale 31.985
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.241
SG - Singapore 2.405
IT - Italia 2.281
CN - Cina 2.069
HK - Hong Kong 1.126
BR - Brasile 816
SE - Svezia 744
VN - Vietnam 740
DE - Germania 679
BG - Bulgaria 402
CA - Canada 372
FR - Francia 316
GB - Regno Unito 307
FI - Finlandia 253
TR - Turchia 236
RU - Federazione Russa 195
IN - India 167
JP - Giappone 162
AT - Austria 156
KR - Corea 137
CI - Costa d'Avorio 125
PL - Polonia 102
UA - Ucraina 93
NL - Olanda 75
BD - Bangladesh 72
IQ - Iraq 54
AR - Argentina 52
MX - Messico 52
CH - Svizzera 48
ZA - Sudafrica 38
PK - Pakistan 30
UZ - Uzbekistan 30
SA - Arabia Saudita 29
SN - Senegal 29
EC - Ecuador 27
BE - Belgio 26
VE - Venezuela 25
CO - Colombia 24
ES - Italia 23
ID - Indonesia 21
JM - Giamaica 18
MA - Marocco 18
KE - Kenya 17
TW - Taiwan 17
DK - Danimarca 16
EG - Egitto 15
JO - Giordania 15
MY - Malesia 15
PH - Filippine 15
TN - Tunisia 15
NG - Nigeria 14
PE - Perù 14
AU - Australia 13
CL - Cile 13
IR - Iran 13
AE - Emirati Arabi Uniti 12
CZ - Repubblica Ceca 12
HN - Honduras 11
IL - Israele 11
LT - Lituania 11
AZ - Azerbaigian 10
GR - Grecia 10
HU - Ungheria 10
KZ - Kazakistan 10
PS - Palestinian Territory 10
CR - Costa Rica 9
PY - Paraguay 9
DZ - Algeria 8
GT - Guatemala 8
IE - Irlanda 8
BO - Bolivia 7
KG - Kirghizistan 7
UY - Uruguay 7
HR - Croazia 6
OM - Oman 6
PT - Portogallo 6
RO - Romania 6
SV - El Salvador 6
AL - Albania 5
NP - Nepal 5
PR - Porto Rico 5
AO - Angola 4
BJ - Benin 4
DO - Repubblica Dominicana 4
EU - Europa 4
LB - Libano 4
LK - Sri Lanka 4
LU - Lussemburgo 4
MD - Moldavia 4
MK - Macedonia 4
NI - Nicaragua 4
TT - Trinidad e Tobago 4
AM - Armenia 3
ET - Etiopia 3
GH - Ghana 3
SY - Repubblica araba siriana 3
TH - Thailandia 3
TZ - Tanzania 3
XK - ???statistics.table.value.countryCode.XK??? 3
YE - Yemen 3
Totale 31.290
Salva come PNG Salva come JPEG
Città #
Ashburn 1.535
Singapore 1.368
Woodbridge 1.143
Hong Kong 1.097
Ann Arbor 968
Fairfield 901
San Jose 894
Santa Clara 760
Chandler 734
Dallas 730
Houston 685
Serra 491
Beijing 424
Milan 418
Seattle 406
Sofia 401
Shanghai 389
Council Bluffs 361
Wilmington 339
New York 320
Cambridge 303
Boardman 263
Ottawa 248
Los Angeles 244
Hefei 197
Princeton 172
Ho Chi Minh City 161
Lawrence 157
Frankfurt am Main 146
Vienna 142
Lauterbourg 140
Tokyo 139
Chicago 138
Hanoi 137
Izmir 133
Medford 127
Abidjan 125
Seoul 123
Nanjing 122
Munich 120
Pisa 115
Jacksonville 113
Dong Ket 106
Rome 105
Helsinki 97
Buffalo 94
Florence 92
Des Moines 91
London 87
Warsaw 85
Atlanta 78
São Paulo 76
Istanbul 69
Redondo Beach 64
Orem 59
San Diego 58
Dearborn 42
Marseille 42
Boulder 41
Redwood City 40
Salt Lake City 40
Livorno 38
Columbus 37
Da Nang 37
Phoenix 37
Nanchang 36
Ogden 34
Lucca 33
Toronto 33
Washington 33
Naples 32
The Dalles 32
Brooklyn 31
Dakar 29
Montreal 29
Changsha 28
Turku 28
Denver 27
Shenyang 27
Tianjin 27
Zurich 27
Fuzhou 25
Memphis 25
Amsterdam 24
Nuremberg 24
Nürnberg 24
Tashkent 24
Brussels 23
Guangzhou 23
Lappeenranta 23
Rio de Janeiro 23
Bremen 22
Chennai 22
Lancaster 22
Pune 22
Kunming 21
Baltimore 20
Johannesburg 20
Quanzhou 20
Bern 19
Totale 20.356
Salva come PNG Salva come JPEG
Nome #
Anti-Inflammatory and Vasorelaxant Effects Induced by an Aqueous Aged Black Garlic Extract Supplemented with Vitamins D, C, and B12 on Cardiovascular System 659
1,2,3-Triazol-carboxanilides and 1,2,3-triazol-(N-benzyl)-carboxamides as BK-potassium channel activators. XII 399
Resveratrol-like Compounds as SIRT1 Activators 394
Metformin conjugates and therapeutic use thereof 392
First examples of H2S-releasing glycoconjugates: stereoselective synthesis and anticancer activities 384
Vascular Effects of p-Carboxyphenyl-Isothiocyanate, a novel H2S-donor 315
Different patterns of H2S/NO activity and cross-talk in the control of the coronary vascular bed under normotensive or hypertensive conditions 311
Design and synthesis of 2-oxindole based multi-targeted inhibitors of PDK1/Akt signaling pathway for the treatment of glioblastoma multiforme 304
Iminothioethers as Hydrogen Sulfide Donors: From the Gasotransmitter Release to the Vascular Effects 301
N(6)-1,3-diphenylurea derivatives of 2-phenyl-9-benzyladenines and 8-azaadenines: Synthesis and biological evaluation as allosteric modulators of A(2A) adenosine receptors 296
The Citrus Flavanone Naringenin Protects Myocardial Cells against Age-Associated Damage 293
Anti-Inflammatory and Antioxidant Effects Induced by Allium sativum L. Extracts on an Ex Vivo Experimental Model of Ulcerative Colitis 287
Beneficial Effects of Eruca sativa Defatted Seed Meal on Visceral Pain and Intestinal Damage Resulting from Colitis in Rats 279
Palmitoylethanolamide Counteracts Enteric Inflammation and Bowel Motor Dysfunctions in a Mouse Model of Alzheimer’s Disease 275
The Citrus Flavonoid Naringenin Protects the Myocardium from Ageing-Dependent Dysfunction: Potential Role of SIRT1 263
New activators of SIRT1 enzyme for the treatment of cardiovascular and cardiometabolic pathologies 256
The citrus flavanone naringenin produces cardioprotective effects in hearts from 1 year old rat, through activation of mitoBK channels 246
The novel H2S-donor 4-carboxyphenyl isothiocyanate promotes cardioprotective effects against ischemia/reperfusion injury through activation of mitoKATP channels and reduction of oxidative stress 244
An Evaluation of the Effects of Pineapple-Extract and Bromelain-Based Treatment after Mandibular Third Molar Surgery: A Randomized Three-Arm Clinical Study 240
The activation of mitochondrial BK potassium channels contributes to the protective effects of naringenin against myocardial ischemia/reperfusion injury 240
Hydrogen sulfide releasing capacity of natural isothiocyanates: is it a reliable explanation for the multiple biological effects of brassicaceae? 240
Synthesis and evaluation of multi-functional NO-donor/insulin-secretagogue derivatives for the treatment of type II diabetes and its cardiovascular complications 239
Impact of thermal processing on polyphenols, carotenoids, glucosinolates, and ascorbic acid in fruit and vegetables and their cardiovascular benefits 234
Design, synthesis and biological evaluation of new H2S-releasing rivastigmine derivatives as neuroprotective molecules 233
1,4-Benzothiazine ATP-Sensitive Potassium Channel Openers: Modifications at the C-2 and C-6 Positions 231
Anti-Inflammatory Effect of the Natural H2S-Donor Erucin in Vascular Endothelium 229
Protective effect of high-dose montelukast on salbutamol-induced homologous desensitisation in airway smooth muscle. 228
Nuovi attivatori dell’enzima SIRT1 per il trattamento delle patologie cardiovascolari e cardiometaboliche 226
Glucoerucin, Glucosinolate From Brassicaceae Vegetables, Improves the Metabolic Profile in a Murine Model of Diet-Induced Obesity 226
New NO-Releasing Pharmacodynamic Hybrids of Losartan and Its Active Metabolite: Design,Synthesis, and Biopharmacological Properties 223
Dietary Supplementation with the Probiotic SF68 Reinforces Intestinal Epithelial Barrier in Obese Mice by Improving Butyrate Bioavailability 222
A NEW NITRIC OXIDE RELEASING ANTI-DIABETIC HYBRID DRUG: FROM THE DESIGN TO THE PHARMACOLOGICAL CHARACTERIZATION 218
Prodromal Intestinal Events in Alzheimer's Disease (AD): Colonic Dysmotility and Inflammation Are Associated with Enteric AD-Related Protein Deposition 218
Sirtuin 1-Activating Compounds: Discovery of a Class of Thiazole-Based Derivatives 217
Arylthioamides as H2S Donors:l-Cysteine-Activated Releasing Properties and Vascular Effects in Vitro and in Vivo 206
A Series of COX-2 Inhibitors Endowed with NO-Releasing Properties: Synthesis, Biological Evaluation, and Docking Analysis 206
Hydrogen Sulphide: Biopharmacological Roles in the Cardiovascular System and Pharmaceutical Perspectives. 204
Design and synthesis of H2S-donor hybrids: A new treatment for Alzheimer's disease? 202
Synthesis and biological activity of novel substituted benzanilides as potassium channel activators. V 200
NSAID-induced enteropathy: are the currently available selective COX-2 inhibitors all the same? 199
Alteration of endogenous purinergic modulation of tracheal neurotransmission in sensitised guinea-pigs 197
Pharmacological characterization of the vascular effects of aryl isothiocyanates: Is hydrogen sulfide the real player? 196
ROLE OF ENDOTHELIAL NO IN THE VASORELAXING EFFECTS INDUCED BY H2S IN CONDUCTANCE AND RESISTANCE RAT ARTERIES 191
Pharmacological study on the cardiovascular activity of no-sartans, pharmacodynamic hybridsexhibiting at1-antagonist and no-donor properties 189
VASORELAXATION BY HYDROGEN SULPHIDE INVOLVES ACTIVATION OF KV7 POTASSIUM CHANNELS 189
Spirocyclic Benzopyran-based derivatives as new anti-ischemic activators of mitochondrial ATP-sensitive potassium channel 188
New amido derivatives as potential BKCa potassium channel activators. XI 187
Voltage-operated potassium (Kv) channels contribute to endothelium-dependent vasorelaxation of carvacrol on rat aorta 187
ANTI-ISCHEMIC PROPERTIES OF A NEW SPIRO-CYCLIC BENZOPYRAN ACTIVATOR OF CARDIAC MITOCHONDRIAL ATP-SENSITIVE POTASSIUM CHANNELS 182
Phosphorylation of AKT and ERK1/2 and mutations of PIK3CA and PTEN are predictive of breast cancer cell sensitivity to everolimus in vitro 181
Mitochondriotropic and Cardioprotective Effects of Triphenylphosphonium-Conjugated Derivatives of the Diterpenoid Isosteviol 181
VASORELAXING EFFECTS OF H2S IN RAT MESENTERIC ARTERIES 180
New Benzopyran-Based Openers of the Mitochondrial ATP-Sensitive Potassium Channel with Potent Anti-Ischemic Properties 180
Differential Effects of Fondaparinux and Bemiparin on Angiogenic and Vasculogenesis-like processes. 178
Development of fortified citrus olive oils: From their production to their nutraceutical properties on the cardiovascular system 178
Large conductance Ca2+-activated K+ channel (BKCa) activating properties of a series of novel N-arylbenzamides: Channel subunit dependent effects 177
NO-Sartans: A New Class of Pharmacodynamic Hybrids as Cardiovascular Drugs 176
Anti-ischemic properties of a new spiro-cyclic benzopyran activator of the cardiac mito-KATP channel 176
Mitochondrial Potassium Channels as Pharmacological Target for Cardioprotective Drugs 176
(+/-)-NARINGENIN AS LARGE CONDUCTANCE Ca2+-ACTIVATED K+ (BKCa) CHANNEL OPENER IN VASCULAR SMOOTH MUSCLE CELLS 176
Anticancer properties of erucin, an H2S-releasing isothiocyanate, on human pancreatic adenocarcinoma cells (AsPC-1) 175
Erucin exhibits vasorelaxing effects and antihypertensive activity by H 2 S-releasing properties 174
H2S-RELEASING PROPERTIES OF NEW THIOAMIDE, IMINOTHIOETHER AND ISOTHIOCYANATE DERIVATIVES 173
Iminothioethers as a novel class of H2S-donor: gasotransmitter release and vascular effects 173
H2S donating corticosteroids: Design, synthesis and biological evaluation in a murine model of asthma 172
NOVEL ANALGESIC/ANTI-INFLAMMATORY AGENTS: 1,5-DIARYLPYRROLE NITROOXYALKYL ETHERS AND RELATED COMPOUNDS AS CYCLOOXYGENASE-2 INHIBITING NITRIC OXIDE DONORS 169
Effect of glucoraphanin and sulforaphane against chemotherapy-induced neuropathic pain: Kv7 potassium channels modulation by H2S release in vivo 165
1,4- and 2,4-substituted-1,2,3-triazoles as potential potassium channel activators. VII. 161
Novel 1,4-benzothiazine derivatives as large conductance Ca(2+)-activated potassium channel openers 161
Alliaceae versus Brassicaceae for Dyslipidemia: State of the Art and Future Perspectives. Systematic Review and Meta-Analysis of Clinical Studies 158
Enantioresolution, stereochemical characterization and biological activity of a chiral large-conductance calcium-activated potassium channel opener 158
The Renal Outer Medullary Potassium channel (ROMK): an intriguing pharmacological target for an innovative class of diuretic drugs 155
Structure-activity relationships study of isothiocyanates for H2S releasing properties: 3-Pyridyl-isothiocyanate as a new promising cardioprotective agent 155
Enhancing the pharmacodynamic profile of a class of selective COX-2 inhibiting nitric oxide donors. 154
Adherence to Oral Antidiabetic Drugs in Patients with Type 2 Diabetes: Systematic Review and Meta-Analysis 153
VASORELAXATION BY HYDROGEN SULPHIDE INVOLVES ACTIVATION OF KV7 POTASSIUM CHANNELS 152
Synthesis of heterocycle-based analogs of resveratrol and their antitumor and vasorelaxing properties 152
NO-glibenclamide derivatives: prototypes of a new class of nitric oxide-releasing anti-diabetic drugs 152
THIOAMIDE, IMINOTHIOETHER AND ISOTHIOCYANATE DERIVATIVES: CHEMOTYPES OF SLOW H2S-RELEASING AGENTS 151
Functional contribution of the endothelial component to the vasorelaxing effect of resveratrol and NS 1619, activators of the large-conductance calcium-activated potassium channels 151
The role of hydrogen sulfide and H2S-donors in myocardial protection against ischemia/reperfusion injury 151
ACTIVATION OF VASCULAR KV7 POTASSIUM CHANNELS CONTRIBUTES TO THE VASODILATOR EFFECTS OF HYDROGEN SULPHIDE 150
HYDROGEN SULPHIDE: NOVEL OPPORTUNITY FOR DRUG DISCOVERY 149
ANTI-ISCHEMIC ACTIVITY OF AN ANTIOXIDANT ALDOSE REDUCTASE INHIBITOR ON DIABETIC AND NON-DIABETIC RAT HEARTS 147
Evaluation of the NO-releasing properties of NO-donor linkers 147
Pathophysiological role of mitochondrial potassium channels and their modulation by drugs 147
Expression and function of Kv7.4 channels in rat cardiac mitochondria: possible targets for cardioprotection 146
EFFECTS OF TSPO-LIGANDS ON MITOCHONDRIAL VOLUME AND MITOCHONDRIAL MEMBRANE POTENTIAL 145
Anti-Proliferative Properties of the Novel Hybrid Drug Met-ITC, Composed of the Native Drug Metformin with the Addition of an Isothiocyanate H2S Donor Moiety, in Different Cancer Cell Lines 145
Pharmacodynamic hybrids coupling established cardiovascular mechanisms of action with additional nitric oxide releasing properties 144
CARDIOVASCULAR EFFECTS OF A NEW NO-RELEASING COXIB DERIVATIVE 141
Persulfidation of mitoKv7.4 channels contributes to the cardioprotective effects of the H2S-donor Erucin against ischemia/reperfusion injury 140
Efficacy of isothiocyanate-based compounds on different forms of persistent pain 140
New Synthetic Analogues of Natural Polyphenols as Sirtuin 1-Activating Compounds 139
IMPROVING THE SOLUBILITY OF A NEW CLASS OF ANTIINFLAMMATORY PHARMACODYNAMIC HYBRIDS, THAT RELEASE NITRIC OXIDE AND INHIBIT CYCLOXYGENASE-2 ISOENZYME 138
The Efficacy of Camelina sativa Defatted Seed Meal against Colitis-Induced Persistent Visceral Hypersensitivity: The Relevance of PPAR α Receptor Activation in Pain Relief 137
QSAR Studies on BK Channel Activators 137
(+/-)-NARINGENIN AS KCA 1.1 CHANNEL OPENER IN VASCULAR SMOOTH MUSCLE CELLS 136
The novel anti-inflammatory agent VA694, endowed with both NO-releasing and COX2-selective inhibiting properties, exhibits NO-mediated positive effects on blood pressure, coronary flow and endothelium in an experimental model of hypertension and endothelial dysfunction 136
Anomalous Kv7 channel activity in human malignant hyperthermia syndrome unmasks a key role for H2S and persulfidation in skeletal muscle 135
Totale 20.508
Salva come PNG Salva come JPEG
Categoria #
all - tutte 88.419
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 88.419
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.775 0 137 51 77 300 289 54 95 89 59 137 487
2022/20232.582 297 340 166 211 266 342 20 169 549 17 122 83
2023/20241.858 161 231 222 108 269 333 96 54 30 39 94 221
2024/20256.265 65 252 94 351 526 709 453 349 595 799 814 1.258
2025/20268.085 391 901 805 613 821 684 1.369 416 584 772 284 445
2026/20272.933 916 2.017 0 0 0 0 0 0 0 0 0 0
Totale 31.985